Impact of atrial fibrillation on the cognitive decline in Alzheimer’s disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-9193
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Impact of atrial fibrillation on the cognitive decline in Alzheimer’s disease ; volume:15 ; number:1 ; day:13 ; month:1 ; year:2023 ; pages:1-8 ; date:12.2023
Alzheimer's research & therapy ; 15, Heft 1 (13.1.2023), 1-8, 12.2023
- Urheber
-
Nakase, Taizen
Tatewaki, Yasuko
Thyreau, Benjamin
Odagiri, Hayato
Tomita, Naoki
Yamamoto, Shuzo
Takano, Yumi
Muranaka, Michiho
Taki, Yasuyuki
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13195-023-01165-1
- URN
-
urn:nbn:de:101:1-2023032221000875212349
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Nakase, Taizen
- Tatewaki, Yasuko
- Thyreau, Benjamin
- Odagiri, Hayato
- Tomita, Naoki
- Yamamoto, Shuzo
- Takano, Yumi
- Muranaka, Michiho
- Taki, Yasuyuki
- SpringerLink (Online service)
Ähnliche Objekte (12)
Awareness of Olfactory Dysfunction in Subjective Cognitive Decline, Mild Cognitive Decline, and Alzheimer’s Disease
Atrial Fibrillation, Cognitive Decline, and Dementia: an Epidemiologic Review
Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer’s disease
Progressive cervical cord atrophy parallels cognitive decline in Alzheimer’s disease
The Alzheimer’s Prevention Initiative Composite Cognitive Test: a practical measure for tracking cognitive decline in preclinical Alzheimer’s disease
Application of Digital Cognitive Biomarkers for Alzheimer’s Disease: Identifying Cognitive Process Changes and Impending Cognitive Decline
Predicting progression and cognitive decline in amyloid-positive patients with Alzheimer’s disease
Lewy body pathology exacerbates brain hypometabolism and cognitive decline in Alzheimer’s disease
Cerebrospinal Fluid Cortisol and Dehydroepiandrosterone Sulfate, Alzheimer’s Disease Pathology, and Cognitive Decline
Longitudinal Cognitive Decline in Patients With Mild Cognitive Impairment or Dementia Due to Alzheimer’s Disease
Lower cerebral blood flow is associated with faster cognitive decline in Alzheimer’s disease
Alzheimer’s and neurodegenerative disease biomarkers in blood predict brain atrophy and cognitive decline
Awareness of Olfactory Dysfunction in Subjective Cognitive Decline, Mild Cognitive Decline, and Alzheimer’s Disease
Atrial Fibrillation, Cognitive Decline, and Dementia: an Epidemiologic Review
Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer’s disease
Progressive cervical cord atrophy parallels cognitive decline in Alzheimer’s disease
The Alzheimer’s Prevention Initiative Composite Cognitive Test: a practical measure for tracking cognitive decline in preclinical Alzheimer’s disease
Application of Digital Cognitive Biomarkers for Alzheimer’s Disease: Identifying Cognitive Process Changes and Impending Cognitive Decline
Predicting progression and cognitive decline in amyloid-positive patients with Alzheimer’s disease
Lewy body pathology exacerbates brain hypometabolism and cognitive decline in Alzheimer’s disease
Cerebrospinal Fluid Cortisol and Dehydroepiandrosterone Sulfate, Alzheimer’s Disease Pathology, and Cognitive Decline
Longitudinal Cognitive Decline in Patients With Mild Cognitive Impairment or Dementia Due to Alzheimer’s Disease
Lower cerebral blood flow is associated with faster cognitive decline in Alzheimer’s disease
Alzheimer’s and neurodegenerative disease biomarkers in blood predict brain atrophy and cognitive decline
Awareness of Olfactory Dysfunction in Subjective Cognitive Decline, Mild Cognitive Decline, and Alzheimer’s Disease
Atrial Fibrillation, Cognitive Decline, and Dementia: an Epidemiologic Review
Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer’s disease
Progressive cervical cord atrophy parallels cognitive decline in Alzheimer’s disease
The Alzheimer’s Prevention Initiative Composite Cognitive Test: a practical measure for tracking cognitive decline in preclinical Alzheimer’s disease
Application of Digital Cognitive Biomarkers for Alzheimer’s Disease: Identifying Cognitive Process Changes and Impending Cognitive Decline
Predicting progression and cognitive decline in amyloid-positive patients with Alzheimer’s disease
Lewy body pathology exacerbates brain hypometabolism and cognitive decline in Alzheimer’s disease
Cerebrospinal Fluid Cortisol and Dehydroepiandrosterone Sulfate, Alzheimer’s Disease Pathology, and Cognitive Decline
Longitudinal Cognitive Decline in Patients With Mild Cognitive Impairment or Dementia Due to Alzheimer’s Disease
Lower cerebral blood flow is associated with faster cognitive decline in Alzheimer’s disease